Characterization of phosphodiesterase 1 in human malignant melanoma cell lines

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1119-1122

  Shimizu, Kasumi ^a   Murata, Taku ^a   Watanabe, Yoshihiro ^a   Sato, C H U ^a   Morita, Hiroshi ^a   Tagawa, Toshiro ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Malignant melanoma; Phodiesterase; Phos; Phosphodiesterase 1

Indexed keywords

MESSENGER RNA; PHOSPHODIESTERASE I; VINPOCETINE;

AMINO ACID SEQUENCE; ARTICLE; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG TARGETING; HUMAN; HUMAN CELL; MELANOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIHYPERTENSIVE AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 1; HUMANS; MELANOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VINCA ALKALOIDS;

EID: 64949091042     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Morris HR, Taylor GW, Masento MS, Jermyn KA and Kay RR: Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum. Nature 328: 811-814, 1987.
2. Kubohara Y, Saito Y and Tatemoto K: Differentiation-inducing factor of D. discoideum raises intracellular calcium concentration and suppresses cell growth in rat pancreatic AR42J cells. FEBS Lett 359: 119-122, 1995.
3. Kubohara Y: DIF-1, putative morphogen of D. discoideum, suppresses cell growth and promotes retinoic acid-induced cell differentiation in HL-60. Biochem Biophys Res Commu 236: 418-422, 1997.
4. Kubohara Y: Effects of differentiation-inducing factors of Dictyostelium discoideum on human leukemia K562 cells: DIF- 3 is the most potent anti-leukemic agent. Eur J Pharmacol 381: 57-62, 1999.
5. Kubohara Y and Hosaka K: The putative morphogen, DIF-1, of Dictyostelium discoideum activates Akt/PKB in human leukemia K562 cells. Biochem Biophys Res Commun 263: 790-796, 1999.
6. 1 arrest and differentiation of vascular smooth muscle cells. Circ Res 86: 68-75, 2000.
7. Kanai M, Konda Y, Nakajima T, Izumi Y, Kanda N, Nanakin A, Kubohara Y and Chiba T: Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK dependent pathway. Oncogene 22: 548-554, 2003.
8. Shimizu K, Murata T, Tagawa T, Takahashi K, Ishikawa R, Abe Y, Hosaka K and Kubohara Y: Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium. Cancer Res 64: 2568-2571, 2004.
9. Francis SH, Turko IV and Corbin JD: Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucleic Acid Res Mol Biol 65: 1-52, 2001.
10. Bender AT: Calmodulin-stimulated cyclic nucleotide phosphodiesterases. In: Cyclic Nucleotide Phosphodiesterases in Health and Disease. Beavo JA, Francis SH and Houslay MD (eds.). Boca Raton, CRC Press, pp. 35-59, 2007.
11. Kamei T, Inui M, Nakamura S, Okumura K, Goto A and Tagawa T: Interferon-γ and anti-Fas antibody-induced apoptosis in human melanoma cell lines and its relationship to bcl-2 cleavage and bak expression. Melanoma Res 13: 153-159, 2003.
12. Loughney K, Martins TJ, Harris EA, Sadhu K, Hicks JB, Sonnenburg WK, Beavo JA and Ferguson K: Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3',5'-cyclic nucleotide phosphodiesterases. J Biol Chem 271: 796-806, 1996.
13. Drees M, Zimmermann R and Eisenbrand G: 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition. Cancer Res 53: 3058-3061, 1993.
14. White JB, Thompson WJ and Pittler SJ: Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6. Mol Vis 10: 738-749, 2004.
15. Ahlstrom M, Pekkinen M, Huttunen M, Lamberg-Allardt C: Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells. Biochem Pharmacol 69: 267-275, 2005.
16. Jiang X, Li J, Paskind M and Epstein PM: Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells. Proc Natl Acad Sci USA 93: 11236- 11241,1996.
17. 2+ in human CNS tumour cells and in non-malignant and malignant cells of rat origin. J Neurochem 93: 321-329, 2005.
18. Han P, Werber J, Surana M, Fleischer N and Michaeli T: The calcium/calmodulin-dependent phosphodiesterase PDE1C down- regulates glucose-induced insulin secretion. J Biol Chem 274: 22337-22344, 1999.
19. Rybalkin SD, Rybalkina I, Beavo JA and Bornfeldt KE: Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation. Circ Res 90: 151-157, 2008.